Studying cytochrome P450 kinetics in drug metabolism

被引:1
作者
Kramer, Melissa A. [1 ]
Tracy, Timothy S. [1 ]
机构
[1] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA
关键词
atypical; biphasic; cytochrome P450; hepatocytes; heterotropic activation kinetics; K-m; microsomes; sigmoidal; substrate inhibition; V-max;
D O I
10.1517/17425255.4.5.591
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Determination of cytochrome P450 enzyme-mediated kinetics in vitro can be useful for predicting drug dosing and clearance in humans. Expressed P450s, human liver microsomes, human hepatocytes (both fresh and cryopreserved), and human liver slices are used to estimate Km and V-max values for determination of intrinsic clearance of the drug for scale-up to predict in vivo clearance. Objective: To describe the advantages and disadvantages of the various in vitro systems used to estimate kinetic parameters for disposition of drugs and the various kinetic profiles that can be observed. Methods: A review of the literature was conducted to evaluate the utility of the various in vitro preparations, the methods for determining kinetic parameters and the types of kinetic profiles that may be observed. Results/conclusions: The choice of in vitro system for determining kinetic parameters will depend on the objective of the studies, as each system has advantages and disadvantages. Kinetic parameter determinations must be carefully assessed to assure that the correct kinetic model is applied and the most accurate kinetic parameters are determined.
引用
收藏
页码:591 / 603
页数:13
相关论文
共 74 条
[21]   Cryopreservation of rat, dog and human hepatocytes:: influence of preculture and cryoprotectants on recovery, cytochrome P450 activities and induction upon thawing [J].
Gomez-Lechon, M. J. ;
Lahoz, A. ;
Jimenez, N. ;
Castell, J. Vicente ;
Donato, M. T. .
XENOBIOTICA, 2006, 36 (06) :457-472
[22]   Human Hepatocytes in primary culture:: The choice to investigate drug metabolism in man [J].
Gómez-Lechón, MJ ;
Donato, MT ;
Castell, JV ;
Jover, R .
CURRENT DRUG METABOLISM, 2004, 5 (05) :443-462
[23]   USE OF HUMAN HEPATOCYTE CULTURES FOR DRUG-METABOLISM STUDIES [J].
GUILLOUZO, A ;
MOREL, F ;
FARDEL, O ;
MEUNIER, B .
TOXICOLOGY, 1993, 82 (1-3) :209-219
[24]   LONG-TERM CULTURE OF FUNCTIONAL HEPATOCYTES [J].
GUILLOUZO, A ;
MOREL, F ;
RATANASAVANH, D ;
CHESNE, C ;
GUGUENGUILLOUZO, C .
TOXICOLOGY IN VITRO, 1990, 4 (4-5) :415-&
[25]   Stability of cytochrome P450 proteins in cultured precision-cut rat liver slices [J].
Hashemi, E ;
Till, C ;
Ioannides, C .
TOXICOLOGY, 2000, 149 (2-3) :51-61
[26]   Evaluation of microsomal incubation conditions on CYP3A4-mediated metabolism of cyclosporine a by a statistical experimental design [J].
Hermann, M ;
Kase, ET ;
Molden, E ;
Christensen, H .
CURRENT DRUG METABOLISM, 2006, 7 (03) :265-271
[27]   Metabolic activity of fresh and cryopreserved cynomolgus monkey (Macaca fascicularis) hepatocytes [J].
Hewitt, NJ ;
Fischer, T ;
Zuehlke, U ;
Oesch, F ;
Utesch, D .
XENOBIOTICA, 2000, 30 (07) :665-681
[28]  
Hewitt NJ, 2001, DRUG METAB DISPOS, V29, P1042
[29]  
Hickman D, 1998, DRUG METAB DISPOS, V26, P207
[30]   Effector-mediated alteration of substrate orientation in cytochrorne P4502C9 [J].
Hummel, MA ;
Gannett, PM ;
Aguilar, JS ;
Tracy, TS .
BIOCHEMISTRY, 2004, 43 (22) :7207-7214